Ye, Junjie
Sun, Xiaodong
Jiang, Qi
Gui, Jianjun
Feng, Shenglan
Qin, Bingqing
Xie, Lixia
Guo, Ai
Dong, Jinju
Sang, Ming http://orcid.org/0000-0003-2322-0674
Funding for this research was provided by:
Innovative research program for graduates of Hubei University of Medicine (YC2022003, YC2022008, YC2023006, YC2024017, YC2024030)
The Foundation of Health Commission of Hubei Province (WJ2023M161)
the Open Fund Hubei Provincial Clinical Research Center for Umbilical Cord Blood Hematopoietic Stem Cells, Taihe Hospital (2024SCOF004)
Innovative Research Program of Xiangyang No.1 People's Hospital (XYY2023ZY04)
This work was supported by the Experimental Animal Resources Development and Utilization Project of Hubei Province of China (2020DFE025)
Article History
Received: 9 May 2024
Accepted: 14 August 2024
First Online: 14 September 2024
Declarations
:
: The collection of umbilical cord blood samples was approved under the title “Effect and mechanism of human cord blood plasma exosomes on Parkinson's disease” by the Ethics Committee of Xiangyang No.1 People’s Hospital (XYYYE20210009) on November 30, 2021, and all donors signed the informed consent. The animal experiments in this study have been approved under the title “Effect and mechanism of human cord blood plasma exosomes on Parkinson's disease” by the Ethical Committee for Animal Experimentation of Xiangyang No.1 People's Hospital (2021DW009) on July 27, 2021.
: Not applicable.
: The authors declare that they have no competing interests.